

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 4.28100580 |
| 2 | neuron cell-cell adhesion (GO:0007158) | 4.21780297 |
| 3 | axonemal dynein complex assembly (GO:0070286) | 4.21719157 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.15188532 |
| 5 | epithelial cilium movement (GO:0003351) | 4.02782296 |
| 6 | synaptic vesicle maturation (GO:0016188) | 4.01718554 |
| 7 | cilium movement (GO:0003341) | 3.98434090 |
| 8 | locomotory exploration behavior (GO:0035641) | 3.97396167 |
| 9 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.93380331 |
| 10 | central nervous system myelination (GO:0022010) | 3.87030351 |
| 11 | axon ensheathment in central nervous system (GO:0032291) | 3.87030351 |
| 12 | neuronal action potential propagation (GO:0019227) | 3.75238508 |
| 13 | cellular potassium ion homeostasis (GO:0030007) | 3.74686155 |
| 14 | vocalization behavior (GO:0071625) | 3.74484789 |
| 15 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.69104184 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.68960013 |
| 17 | protein localization to synapse (GO:0035418) | 3.67425317 |
| 18 | glutamate secretion (GO:0014047) | 3.61747347 |
| 19 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.60872484 |
| 20 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.51119307 |
| 21 | neuron recognition (GO:0008038) | 3.46941566 |
| 22 | positive regulation of mitochondrial fission (GO:0090141) | 3.45592212 |
| 23 | intraciliary transport (GO:0042073) | 3.44494202 |
| 24 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.42153468 |
| 25 | layer formation in cerebral cortex (GO:0021819) | 3.41561614 |
| 26 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.40245858 |
| 27 | exploration behavior (GO:0035640) | 3.39348414 |
| 28 | sodium ion export (GO:0071436) | 3.32468690 |
| 29 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.30020869 |
| 30 | axonal fasciculation (GO:0007413) | 3.25345068 |
| 31 | regulation of synapse structural plasticity (GO:0051823) | 3.22813378 |
| 32 | cell communication by electrical coupling (GO:0010644) | 3.21564456 |
| 33 | transmission of nerve impulse (GO:0019226) | 3.20608464 |
| 34 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.19881028 |
| 35 | dendritic spine morphogenesis (GO:0060997) | 3.18316258 |
| 36 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.18198583 |
| 37 | glutamate receptor signaling pathway (GO:0007215) | 3.18189847 |
| 38 | regulation of synaptic vesicle transport (GO:1902803) | 3.17961640 |
| 39 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.14414845 |
| 40 | establishment of mitochondrion localization (GO:0051654) | 3.11103314 |
| 41 | nucleobase catabolic process (GO:0046113) | 3.06907102 |
| 42 | response to auditory stimulus (GO:0010996) | 3.02229904 |
| 43 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.02219185 |
| 44 | innervation (GO:0060384) | 3.01696909 |
| 45 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.00159864 |
| 46 | synaptic transmission, glutamatergic (GO:0035249) | 2.97544104 |
| 47 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.97119737 |
| 48 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.96470184 |
| 49 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.96358716 |
| 50 | neurotransmitter secretion (GO:0007269) | 2.95749318 |
| 51 | potassium ion homeostasis (GO:0055075) | 2.94052504 |
| 52 | presynaptic membrane assembly (GO:0097105) | 2.93901658 |
| 53 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.93322144 |
| 54 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.92423904 |
| 55 | long-term synaptic potentiation (GO:0060291) | 2.91912065 |
| 56 | neuron-neuron synaptic transmission (GO:0007270) | 2.90165396 |
| 57 | postsynaptic membrane organization (GO:0001941) | 2.89356829 |
| 58 | response to pheromone (GO:0019236) | 2.86676182 |
| 59 | membrane repolarization (GO:0086009) | 2.86126307 |
| 60 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.84459661 |
| 61 | presynaptic membrane organization (GO:0097090) | 2.84253741 |
| 62 | regulation of vesicle fusion (GO:0031338) | 2.82083639 |
| 63 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.80187485 |
| 64 | neurotransmitter catabolic process (GO:0042135) | 2.79726466 |
| 65 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.79267273 |
| 66 | dendrite morphogenesis (GO:0048813) | 2.79235415 |
| 67 | potassium ion import (GO:0010107) | 2.79024298 |
| 68 | positive regulation of potassium ion transport (GO:0043268) | 2.78880304 |
| 69 | retinal ganglion cell axon guidance (GO:0031290) | 2.78860657 |
| 70 | mating behavior (GO:0007617) | 2.76083420 |
| 71 | positive regulation of synapse assembly (GO:0051965) | 2.74054190 |
| 72 | membrane hyperpolarization (GO:0060081) | 2.73891685 |
| 73 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.73749198 |
| 74 | synapse assembly (GO:0007416) | 2.72685593 |
| 75 | nonmotile primary cilium assembly (GO:0035058) | 2.70386511 |
| 76 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.69406992 |
| 77 | regulation of cilium movement (GO:0003352) | 2.68858884 |
| 78 | negative regulation of neurotransmitter transport (GO:0051589) | 2.67733205 |
| 79 | auditory behavior (GO:0031223) | 2.66882534 |
| 80 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.65142839 |
| 81 | cholesterol biosynthetic process (GO:0006695) | 2.64632125 |
| 82 | neuronal ion channel clustering (GO:0045161) | 2.63850776 |
| 83 | neurotransmitter transport (GO:0006836) | 2.63761084 |
| 84 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.61999458 |
| 85 | C4-dicarboxylate transport (GO:0015740) | 2.61141635 |
| 86 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.60093446 |
| 87 | activation of protein kinase A activity (GO:0034199) | 2.59309633 |
| 88 | mechanosensory behavior (GO:0007638) | 2.58992614 |
| 89 | synapse organization (GO:0050808) | 2.58390167 |
| 90 | synaptic vesicle endocytosis (GO:0048488) | 2.58345426 |
| 91 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.57809826 |
| 92 | long-term memory (GO:0007616) | 2.56416034 |
| 93 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.55582941 |
| 94 | photoreceptor cell differentiation (GO:0046530) | 2.55550383 |
| 95 | eye photoreceptor cell differentiation (GO:0001754) | 2.55550383 |
| 96 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.55392714 |
| 97 | cerebellar granule cell differentiation (GO:0021707) | 2.54640316 |
| 98 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.54573079 |
| 99 | detection of calcium ion (GO:0005513) | 2.53691598 |
| 100 | L-amino acid import (GO:0043092) | 2.53601757 |
| 101 | positive regulation of synapse maturation (GO:0090129) | 2.53422624 |
| 102 | positive regulation of membrane potential (GO:0045838) | 2.53396783 |
| 103 | cilium assembly (GO:0042384) | 2.53016790 |
| 104 | regulation of synaptic plasticity (GO:0048167) | 2.52700885 |
| 105 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.52583704 |
| 106 | membrane repolarization during action potential (GO:0086011) | 2.52264841 |
| 107 | cilium organization (GO:0044782) | 2.52215287 |
| 108 | dendritic spine organization (GO:0097061) | 2.52103730 |
| 109 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.52056367 |
| 110 | proline transport (GO:0015824) | 2.51806162 |
| 111 | motile cilium assembly (GO:0044458) | 2.51565754 |
| 112 | axoneme assembly (GO:0035082) | 2.51250307 |
| 113 | left/right pattern formation (GO:0060972) | 2.50314201 |
| 114 | gamma-aminobutyric acid transport (GO:0015812) | 2.49956073 |
| 115 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.49741979 |
| 116 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.49515119 |
| 117 | regulation of neurotransmitter secretion (GO:0046928) | 2.49332136 |
| 118 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.49015766 |
| 119 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.48324485 |
| 120 | negative regulation of microtubule polymerization (GO:0031115) | 2.48200472 |
| 121 | cellular sodium ion homeostasis (GO:0006883) | 2.46633812 |
| 122 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.45406145 |
| 123 | regulation of respiratory system process (GO:0044065) | 2.44254585 |
| 124 | regulation of membrane repolarization (GO:0060306) | 2.43266503 |
| 125 | primary alcohol catabolic process (GO:0034310) | 2.43122145 |
| 126 | protein retention in ER lumen (GO:0006621) | 2.41497091 |
| 127 | carnitine metabolic process (GO:0009437) | 2.41210489 |
| 128 | sterol biosynthetic process (GO:0016126) | 2.40640504 |
| 129 | cilium morphogenesis (GO:0060271) | 2.40337823 |
| 130 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.39576650 |
| 131 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.39576650 |
| 132 | negative regulation of protein localization to cell surface (GO:2000009) | 2.38170810 |
| 133 | cGMP-mediated signaling (GO:0019934) | 2.36068151 |
| 134 | lipid particle organization (GO:0034389) | 2.34209314 |
| 135 | acidic amino acid transport (GO:0015800) | 2.33089527 |
| 136 | L-serine transport (GO:0015825) | 2.30795628 |
| 137 | peroxisome fission (GO:0016559) | 2.29168035 |
| 138 | protein localization to cilium (GO:0061512) | 2.25915869 |
| 139 | axon extension involved in axon guidance (GO:0048846) | 2.21730065 |
| 140 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.21730065 |
| 141 | vascular smooth muscle contraction (GO:0014829) | 2.21295613 |
| 142 | ethanol oxidation (GO:0006069) | 2.20799618 |
| 143 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.20140345 |
| 144 | L-glutamate transport (GO:0015813) | 2.19693042 |
| 145 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.19561179 |
| 146 | vitamin transmembrane transport (GO:0035461) | 2.18650360 |
| 147 | regulation of mitochondrial fission (GO:0090140) | 2.17805285 |
| 148 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.16899616 |
| 149 | sodium ion homeostasis (GO:0055078) | 2.15532380 |
| 150 | neurotransmitter uptake (GO:0001504) | 2.15414713 |
| 151 | limb development (GO:0060173) | 2.14721840 |
| 152 | appendage development (GO:0048736) | 2.14721840 |
| 153 | polyketide metabolic process (GO:0030638) | 2.13245251 |
| 154 | doxorubicin metabolic process (GO:0044598) | 2.13245251 |
| 155 | daunorubicin metabolic process (GO:0044597) | 2.13245251 |
| 156 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.12977673 |
| 157 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.11734608 |
| 158 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.11285760 |
| 159 | mitochondrion transport along microtubule (GO:0047497) | 2.11285760 |
| 160 | ubiquinone metabolic process (GO:0006743) | 2.08047449 |
| 161 | isoprenoid biosynthetic process (GO:0008299) | 2.07783635 |
| 162 | regulation of cell communication by electrical coupling (GO:0010649) | 2.07549656 |
| 163 | axon extension (GO:0048675) | 2.07324953 |
| 164 | alpha-linolenic acid metabolic process (GO:0036109) | 2.07260751 |
| 165 | oligodendrocyte differentiation (GO:0048709) | 2.05889185 |
| 166 | glycosphingolipid biosynthetic process (GO:0006688) | 2.04511780 |
| 167 | neurotransmitter biosynthetic process (GO:0042136) | 2.02776526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.17632906 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.25982084 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.21878924 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.20148078 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.10515519 |
| 6 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.84438503 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.79170243 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.79170243 |
| 9 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.78490614 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.78290665 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.75908815 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.73004776 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.66285289 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.63476286 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.56406273 |
| 16 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.42389317 |
| 17 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.39864866 |
| 18 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.31143071 |
| 19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.23746389 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.04624764 |
| 21 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.93511776 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.89319162 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89297759 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.83503119 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.83201462 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.79206628 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.79005198 |
| 28 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.77840854 |
| 29 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.69768228 |
| 30 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.67095038 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.65830643 |
| 32 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.63828739 |
| 33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.53942980 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.52163417 |
| 35 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.49841458 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.48312098 |
| 37 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.48281569 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48260732 |
| 39 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.47449399 |
| 40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46014013 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.45767527 |
| 42 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.45545766 |
| 43 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.42713461 |
| 44 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.41747973 |
| 45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.40971927 |
| 46 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.40098022 |
| 47 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38448337 |
| 48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.37294559 |
| 49 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.34766252 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34206026 |
| 51 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.32366423 |
| 52 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32146569 |
| 53 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31471028 |
| 54 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.31344943 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.30588315 |
| 56 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.30280120 |
| 57 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30196125 |
| 58 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.29794353 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29438900 |
| 60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27053207 |
| 61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26284491 |
| 62 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26203984 |
| 63 | VDR_22108803_ChIP-Seq_LS180_Human | 1.22067037 |
| 64 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.19510629 |
| 65 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.16585233 |
| 66 | FUS_26573619_Chip-Seq_HEK293_Human | 1.16516922 |
| 67 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.15684186 |
| 68 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14736838 |
| 69 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.13407687 |
| 70 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11922388 |
| 71 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11470456 |
| 72 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.11391059 |
| 73 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11390216 |
| 74 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.10584722 |
| 75 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.10338435 |
| 76 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.09621500 |
| 77 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.06002431 |
| 78 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.05324640 |
| 79 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04725378 |
| 80 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04669702 |
| 81 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.04534612 |
| 82 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03257355 |
| 83 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.02446302 |
| 84 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.02034203 |
| 85 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01177102 |
| 86 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00730775 |
| 87 | AR_19668381_ChIP-Seq_PC3_Human | 1.00396123 |
| 88 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00107376 |
| 89 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.99250717 |
| 90 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.99026902 |
| 91 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98828044 |
| 92 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98612304 |
| 93 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97771788 |
| 94 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97765699 |
| 95 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96187324 |
| 96 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96179887 |
| 97 | EWS_26573619_Chip-Seq_HEK293_Human | 0.95215059 |
| 98 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94741647 |
| 99 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94431315 |
| 100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94200746 |
| 101 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93086839 |
| 102 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92958369 |
| 103 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.92837716 |
| 104 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.92039674 |
| 105 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.92039674 |
| 106 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91681819 |
| 107 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.90555053 |
| 108 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90013265 |
| 109 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89732441 |
| 110 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89706463 |
| 111 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.88814438 |
| 112 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.88534715 |
| 113 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88367797 |
| 114 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.88201870 |
| 115 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.87593761 |
| 116 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87436245 |
| 117 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86265004 |
| 118 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85791573 |
| 119 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.85778668 |
| 120 | JUN_21703547_ChIP-Seq_K562_Human | 0.85500559 |
| 121 | TCF4_23295773_ChIP-Seq_U87_Human | 0.84216244 |
| 122 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83795894 |
| 123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83498105 |
| 124 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.82824874 |
| 125 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.82484036 |
| 126 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.82093618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.23291566 |
| 2 | MP0003880_abnormal_central_pattern | 4.17812109 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.11454404 |
| 4 | MP0004270_analgesia | 3.10061701 |
| 5 | MP0009745_abnormal_behavioral_response | 2.52175304 |
| 6 | MP0002064_seizures | 2.49672995 |
| 7 | MP0002063_abnormal_learning/memory/cond | 2.45723078 |
| 8 | MP0002272_abnormal_nervous_system | 2.31728668 |
| 9 | MP0002734_abnormal_mechanical_nocicepti | 2.30742372 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.29013462 |
| 11 | MP0001486_abnormal_startle_reflex | 2.28494928 |
| 12 | MP0003329_amyloid_beta_deposits | 2.22825802 |
| 13 | MP0009046_muscle_twitch | 2.22689211 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.20844219 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.16571025 |
| 16 | MP0004858_abnormal_nervous_system | 2.16404294 |
| 17 | MP0003136_yellow_coat_color | 2.01851608 |
| 18 | MP0000778_abnormal_nervous_system | 1.99650071 |
| 19 | MP0008789_abnormal_olfactory_epithelium | 1.86350651 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 1.82221243 |
| 21 | MP0005248_abnormal_Harderian_gland | 1.81985528 |
| 22 | MP0001529_abnormal_vocalization | 1.81132754 |
| 23 | MP0001984_abnormal_olfaction | 1.80694461 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.79309985 |
| 25 | MP0005645_abnormal_hypothalamus_physiol | 1.76219444 |
| 26 | MP0002736_abnormal_nociception_after | 1.74207359 |
| 27 | MP0004885_abnormal_endolymph | 1.73643270 |
| 28 | MP0000566_synostosis | 1.73031390 |
| 29 | MP0001440_abnormal_grooming_behavior | 1.72372826 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.72069284 |
| 31 | MP0006276_abnormal_autonomic_nervous | 1.71600331 |
| 32 | MP0003122_maternal_imprinting | 1.70462067 |
| 33 | MP0002184_abnormal_innervation | 1.68817657 |
| 34 | MP0001970_abnormal_pain_threshold | 1.68502151 |
| 35 | MP0002909_abnormal_adrenal_gland | 1.66743690 |
| 36 | MP0000013_abnormal_adipose_tissue | 1.63310482 |
| 37 | MP0002735_abnormal_chemical_nociception | 1.61702560 |
| 38 | MP0001501_abnormal_sleep_pattern | 1.58187712 |
| 39 | MP0001905_abnormal_dopamine_level | 1.58035464 |
| 40 | MP0001502_abnormal_circadian_rhythm | 1.56826602 |
| 41 | MP0002557_abnormal_social/conspecific_i | 1.56430532 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.55616074 |
| 43 | MP0008569_lethality_at_weaning | 1.54577904 |
| 44 | MP0000955_abnormal_spinal_cord | 1.53693750 |
| 45 | MP0000920_abnormal_myelination | 1.48001235 |
| 46 | MP0003634_abnormal_glial_cell | 1.46601961 |
| 47 | MP0002882_abnormal_neuron_morphology | 1.45197870 |
| 48 | MP0004924_abnormal_behavior | 1.44201557 |
| 49 | MP0005386_behavior/neurological_phenoty | 1.44201557 |
| 50 | MP0000751_myopathy | 1.43253526 |
| 51 | MP0005551_abnormal_eye_electrophysiolog | 1.40141840 |
| 52 | MP0004043_abnormal_pH_regulation | 1.39453732 |
| 53 | MP0004145_abnormal_muscle_electrophysio | 1.38735918 |
| 54 | MP0004133_heterotaxia | 1.37766670 |
| 55 | MP0003283_abnormal_digestive_organ | 1.35149026 |
| 56 | MP0006072_abnormal_retinal_apoptosis | 1.35072987 |
| 57 | MP0004142_abnormal_muscle_tone | 1.33504893 |
| 58 | MP0002837_dystrophic_cardiac_calcinosis | 1.29927016 |
| 59 | MP0001485_abnormal_pinna_reflex | 1.29185277 |
| 60 | MP0002066_abnormal_motor_capabilities/c | 1.25441058 |
| 61 | MP0002638_abnormal_pupillary_reflex | 1.24474901 |
| 62 | MP0002822_catalepsy | 1.23824477 |
| 63 | MP0004811_abnormal_neuron_physiology | 1.23241124 |
| 64 | MP0003011_delayed_dark_adaptation | 1.20724463 |
| 65 | MP0004742_abnormal_vestibular_system | 1.15280956 |
| 66 | MP0000631_abnormal_neuroendocrine_gland | 1.14802889 |
| 67 | MP0000537_abnormal_urethra_morphology | 1.13818219 |
| 68 | MP0005187_abnormal_penis_morphology | 1.13010040 |
| 69 | MP0010030_abnormal_orbit_morphology | 1.12441865 |
| 70 | MP0002233_abnormal_nose_morphology | 1.11451333 |
| 71 | MP0010386_abnormal_urinary_bladder | 1.11381160 |
| 72 | MP0003690_abnormal_glial_cell | 1.10573639 |
| 73 | MP0005623_abnormal_meninges_morphology | 1.08555050 |
| 74 | MP0001963_abnormal_hearing_physiology | 1.07997406 |
| 75 | MP0002229_neurodegeneration | 1.07338614 |
| 76 | MP0002090_abnormal_vision | 1.07208883 |
| 77 | MP0002152_abnormal_brain_morphology | 1.06080308 |
| 78 | MP0001299_abnormal_eye_distance/ | 1.06038219 |
| 79 | MP0003879_abnormal_hair_cell | 1.05840650 |
| 80 | MP0003633_abnormal_nervous_system | 1.05606798 |
| 81 | MP0004233_abnormal_muscle_weight | 1.03359888 |
| 82 | MP0002752_abnormal_somatic_nervous | 1.02844718 |
| 83 | MP0005171_absent_coat_pigmentation | 1.00747963 |
| 84 | MP0005379_endocrine/exocrine_gland_phen | 0.99536211 |
| 85 | MP0004215_abnormal_myocardial_fiber | 0.98399874 |
| 86 | MP0004147_increased_porphyrin_level | 0.97074543 |
| 87 | MP0003137_abnormal_impulse_conducting | 0.96975754 |
| 88 | MP0003631_nervous_system_phenotype | 0.96949215 |
| 89 | MP0004019_abnormal_vitamin_homeostasis | 0.95503215 |
| 90 | MP0005085_abnormal_gallbladder_physiolo | 0.93758766 |
| 91 | MP0002876_abnormal_thyroid_physiology | 0.93702194 |
| 92 | MP0000462_abnormal_digestive_system | 0.93388402 |
| 93 | MP0001293_anophthalmia | 0.91475037 |
| 94 | MP0000026_abnormal_inner_ear | 0.91464240 |
| 95 | MP0002653_abnormal_ependyma_morphology | 0.89986183 |
| 96 | MP0005253_abnormal_eye_physiology | 0.89933643 |
| 97 | MP0003183_abnormal_peptide_metabolism | 0.89302265 |
| 98 | MP0003632_abnormal_nervous_system | 0.87576802 |
| 99 | MP0005391_vision/eye_phenotype | 0.87345554 |
| 100 | MP0001188_hyperpigmentation | 0.87341608 |
| 101 | MP0000604_amyloidosis | 0.84887665 |
| 102 | MP0002234_abnormal_pharynx_morphology | 0.84271092 |
| 103 | MP0003121_genomic_imprinting | 0.83832561 |
| 104 | MP0005394_taste/olfaction_phenotype | 0.83521927 |
| 105 | MP0005499_abnormal_olfactory_system | 0.83521927 |
| 106 | MP0003861_abnormal_nervous_system | 0.82291441 |
| 107 | MP0002102_abnormal_ear_morphology | 0.82052670 |
| 108 | MP0005670_abnormal_white_adipose | 0.80815546 |
| 109 | MP0002249_abnormal_larynx_morphology | 0.79759405 |
| 110 | MP0005195_abnormal_posterior_eye | 0.78060892 |
| 111 | MP0004085_abnormal_heartbeat | 0.77160762 |
| 112 | MP0003942_abnormal_urinary_system | 0.77050864 |
| 113 | MP0002069_abnormal_eating/drinking_beha | 0.76902347 |
| 114 | MP0001664_abnormal_digestion | 0.76222585 |
| 115 | MP0003119_abnormal_digestive_system | 0.75190348 |
| 116 | MP0000534_abnormal_ureter_morphology | 0.73966908 |
| 117 | MP0001348_abnormal_lacrimal_gland | 0.73052122 |
| 118 | MP0004036_abnormal_muscle_relaxation | 0.71085152 |
| 119 | MP0001177_atelectasis | 0.69921205 |
| 120 | MP0000747_muscle_weakness | 0.69505051 |
| 121 | MP0004134_abnormal_chest_morphology | 0.68139324 |
| 122 | MP0002751_abnormal_autonomic_nervous | 0.68029116 |
| 123 | MP0000003_abnormal_adipose_tissue | 0.67978341 |
| 124 | MP0000049_abnormal_middle_ear | 0.67868933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.74284368 |
| 2 | Focal motor seizures (HP:0011153) | 4.41352205 |
| 3 | Myokymia (HP:0002411) | 4.28576602 |
| 4 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.17875625 |
| 5 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.17875625 |
| 6 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.17449594 |
| 7 | Abnormal ciliary motility (HP:0012262) | 4.10416240 |
| 8 | Neurofibrillary tangles (HP:0002185) | 4.10044405 |
| 9 | Rhinitis (HP:0012384) | 3.92351873 |
| 10 | Visual hallucinations (HP:0002367) | 3.82170249 |
| 11 | Retinal dysplasia (HP:0007973) | 3.62633725 |
| 12 | Megalencephaly (HP:0001355) | 3.51461660 |
| 13 | Epileptic encephalopathy (HP:0200134) | 3.47009975 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 3.44884680 |
| 15 | Cerebral inclusion bodies (HP:0100314) | 3.43720035 |
| 16 | Pheochromocytoma (HP:0002666) | 3.40899617 |
| 17 | True hermaphroditism (HP:0010459) | 3.35114805 |
| 18 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.32663477 |
| 19 | Absent/shortened dynein arms (HP:0200106) | 3.32663477 |
| 20 | Occipital encephalocele (HP:0002085) | 3.24673368 |
| 21 | Focal seizures (HP:0007359) | 3.22147449 |
| 22 | Abnormality of the lower motor neuron (HP:0002366) | 3.09773065 |
| 23 | Neuroendocrine neoplasm (HP:0100634) | 3.09496774 |
| 24 | Atonic seizures (HP:0010819) | 3.05069867 |
| 25 | Ankle clonus (HP:0011448) | 2.94543781 |
| 26 | Pancreatic fibrosis (HP:0100732) | 2.77040789 |
| 27 | Type II lissencephaly (HP:0007260) | 2.76669839 |
| 28 | Action tremor (HP:0002345) | 2.72431075 |
| 29 | Hemiparesis (HP:0001269) | 2.69554392 |
| 30 | Exercise-induced muscle cramps (HP:0003710) | 2.67396537 |
| 31 | Hyperglycinemia (HP:0002154) | 2.67356286 |
| 32 | Amyotrophic lateral sclerosis (HP:0007354) | 2.66176980 |
| 33 | Absence seizures (HP:0002121) | 2.65986700 |
| 34 | Progressive cerebellar ataxia (HP:0002073) | 2.65824155 |
| 35 | Degeneration of anterior horn cells (HP:0002398) | 2.52705307 |
| 36 | Abnormality of the anterior horn cell (HP:0006802) | 2.52705307 |
| 37 | Dialeptic seizures (HP:0011146) | 2.44057538 |
| 38 | Truncal ataxia (HP:0002078) | 2.42298015 |
| 39 | Anxiety (HP:0000739) | 2.41883486 |
| 40 | Chronic bronchitis (HP:0004469) | 2.41275400 |
| 41 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.40531199 |
| 42 | Aplasia of the phalanges of the hand (HP:0009802) | 2.40531199 |
| 43 | Aplasia involving bones of the extremities (HP:0009825) | 2.40531199 |
| 44 | Gait imbalance (HP:0002141) | 2.40108541 |
| 45 | Postaxial foot polydactyly (HP:0001830) | 2.39736203 |
| 46 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.38997546 |
| 47 | Generalized tonic-clonic seizures (HP:0002069) | 2.36078245 |
| 48 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.35649872 |
| 49 | Abnormality of glycine metabolism (HP:0010895) | 2.35649872 |
| 50 | Depression (HP:0000716) | 2.34980161 |
| 51 | Molar tooth sign on MRI (HP:0002419) | 2.30373106 |
| 52 | Abnormality of midbrain morphology (HP:0002418) | 2.30373106 |
| 53 | Dysmetria (HP:0001310) | 2.30162963 |
| 54 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.26913776 |
| 55 | Hyperactive renin-angiotensin system (HP:0000841) | 2.24769579 |
| 56 | Nephronophthisis (HP:0000090) | 2.22934328 |
| 57 | Postaxial hand polydactyly (HP:0001162) | 2.19231833 |
| 58 | Abnormal eating behavior (HP:0100738) | 2.19043708 |
| 59 | Hyperglycinuria (HP:0003108) | 2.18021455 |
| 60 | Dysdiadochokinesis (HP:0002075) | 2.17852274 |
| 61 | Limb dystonia (HP:0002451) | 2.17353978 |
| 62 | Increased circulating renin level (HP:0000848) | 2.16376118 |
| 63 | Congenital primary aphakia (HP:0007707) | 2.13432253 |
| 64 | Intention tremor (HP:0002080) | 2.11751844 |
| 65 | Febrile seizures (HP:0002373) | 2.11159438 |
| 66 | Cystic liver disease (HP:0006706) | 2.07595294 |
| 67 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.06974323 |
| 68 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.06974323 |
| 69 | Acute necrotizing encephalopathy (HP:0006965) | 2.05839837 |
| 70 | Pancreatic cysts (HP:0001737) | 2.05513143 |
| 71 | Vaginal atresia (HP:0000148) | 2.05502539 |
| 72 | Central scotoma (HP:0000603) | 2.04901211 |
| 73 | Progressive inability to walk (HP:0002505) | 2.04868659 |
| 74 | EEG with generalized epileptiform discharges (HP:0011198) | 2.04563365 |
| 75 | Broad foot (HP:0001769) | 2.04413668 |
| 76 | Epileptiform EEG discharges (HP:0011182) | 2.03779370 |
| 77 | Genital tract atresia (HP:0001827) | 2.02657835 |
| 78 | Myoglobinuria (HP:0002913) | 2.02416478 |
| 79 | Broad-based gait (HP:0002136) | 2.02120810 |
| 80 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.01730969 |
| 81 | Scanning speech (HP:0002168) | 2.01304177 |
| 82 | Insidious onset (HP:0003587) | 2.00986746 |
| 83 | Termporal pattern (HP:0011008) | 2.00986746 |
| 84 | Medial flaring of the eyebrow (HP:0010747) | 1.97277050 |
| 85 | Prolonged QT interval (HP:0001657) | 1.96752784 |
| 86 | Spastic gait (HP:0002064) | 1.96443440 |
| 87 | Sensorimotor neuropathy (HP:0007141) | 1.96349520 |
| 88 | Humeroradial synostosis (HP:0003041) | 1.95849217 |
| 89 | Synostosis involving the elbow (HP:0003938) | 1.95849217 |
| 90 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.95148597 |
| 91 | Nephrogenic diabetes insipidus (HP:0009806) | 1.94230716 |
| 92 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.93696721 |
| 93 | Peripheral hypomyelination (HP:0007182) | 1.92896443 |
| 94 | Hyperventilation (HP:0002883) | 1.92216884 |
| 95 | Abnormality of the corticospinal tract (HP:0002492) | 1.91042074 |
| 96 | Hypsarrhythmia (HP:0002521) | 1.90540228 |
| 97 | Lissencephaly (HP:0001339) | 1.90081641 |
| 98 | Polyphagia (HP:0002591) | 1.89559677 |
| 99 | Lower limb muscle weakness (HP:0007340) | 1.89307985 |
| 100 | Tubulointerstitial nephritis (HP:0001970) | 1.88254658 |
| 101 | Poor coordination (HP:0002370) | 1.87842362 |
| 102 | Agitation (HP:0000713) | 1.87095400 |
| 103 | Cortical dysplasia (HP:0002539) | 1.86326738 |
| 104 | Clumsiness (HP:0002312) | 1.86177244 |
| 105 | Amblyopia (HP:0000646) | 1.84145188 |
| 106 | Progressive macrocephaly (HP:0004481) | 1.84044470 |
| 107 | Mutism (HP:0002300) | 1.84025740 |
| 108 | Sclerocornea (HP:0000647) | 1.81816341 |
| 109 | Bronchiectasis (HP:0002110) | 1.78214611 |
| 110 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.78077591 |
| 111 | Abnormality of binocular vision (HP:0011514) | 1.77171385 |
| 112 | Diplopia (HP:0000651) | 1.77171385 |
| 113 | Specific learning disability (HP:0001328) | 1.73868048 |
| 114 | Psychosis (HP:0000709) | 1.73134832 |
| 115 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.72924382 |
| 116 | Hypoplasia of the brainstem (HP:0002365) | 1.72924382 |
| 117 | Scotoma (HP:0000575) | 1.72818305 |
| 118 | Congenital hepatic fibrosis (HP:0002612) | 1.72271827 |
| 119 | Drooling (HP:0002307) | 1.72158807 |
| 120 | Excessive salivation (HP:0003781) | 1.72158807 |
| 121 | Abnormality of macular pigmentation (HP:0008002) | 1.71648618 |
| 122 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.71312034 |
| 123 | Short tibia (HP:0005736) | 1.71299589 |
| 124 | Metabolic alkalosis (HP:0200114) | 1.70897614 |
| 125 | Ventricular fibrillation (HP:0001663) | 1.70376583 |
| 126 | Renal dysplasia (HP:0000110) | 1.69470307 |
| 127 | Split foot (HP:0001839) | 1.69178655 |
| 128 | Thickened helices (HP:0000391) | 1.67626986 |
| 129 | Abnormality of the renal medulla (HP:0100957) | 1.66158311 |
| 130 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.65696966 |
| 131 | Poor eye contact (HP:0000817) | 1.65645130 |
| 132 | Abnormal EKG (HP:0003115) | 1.64971074 |
| 133 | Urinary urgency (HP:0000012) | 1.63599180 |
| 134 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.63252610 |
| 135 | Hepatoblastoma (HP:0002884) | 1.62773037 |
| 136 | Buphthalmos (HP:0000557) | 1.62418352 |
| 137 | Hyperaldosteronism (HP:0000859) | 1.61387167 |
| 138 | Increased serum pyruvate (HP:0003542) | 1.61194731 |
| 139 | Limb-girdle muscle atrophy (HP:0003797) | 1.60376686 |
| 140 | Hypoventilation (HP:0002791) | 1.60278924 |
| 141 | Postural instability (HP:0002172) | 1.58061796 |
| 142 | Myotonia (HP:0002486) | 1.57583745 |
| 143 | Fetal akinesia sequence (HP:0001989) | 1.56637513 |
| 144 | Abnormality of glycolysis (HP:0004366) | 1.55801145 |
| 145 | Rapidly progressive (HP:0003678) | 1.55262530 |
| 146 | Oculomotor apraxia (HP:0000657) | 1.53700073 |
| 147 | Arterial tortuosity (HP:0005116) | 1.53475462 |
| 148 | Anencephaly (HP:0002323) | 1.51875303 |
| 149 | Alacrima (HP:0000522) | 1.51319285 |
| 150 | Torticollis (HP:0000473) | 1.51312114 |
| 151 | Poor suck (HP:0002033) | 1.50985879 |
| 152 | Absent speech (HP:0001344) | 1.50975479 |
| 153 | Leukodystrophy (HP:0002415) | 1.50924035 |
| 154 | Renal hypoplasia (HP:0000089) | 1.50619206 |
| 155 | Decreased testicular size (HP:0008734) | 1.50403172 |
| 156 | Hammertoe (HP:0001765) | 1.49413992 |
| 157 | Abnormal neuron morphology (HP:0012757) | 1.49362854 |
| 158 | Abnormality of the motor neurons (HP:0002450) | 1.49362854 |
| 159 | Rimmed vacuoles (HP:0003805) | 1.48426985 |
| 160 | Preaxial hand polydactyly (HP:0001177) | 1.48194519 |
| 161 | Abnormality of renin-angiotensin system (HP:0000847) | 1.47611004 |
| 162 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.44251066 |
| 163 | Narrow forehead (HP:0000341) | 1.43884369 |
| 164 | Chronic hepatic failure (HP:0100626) | 1.40580430 |
| 165 | Atelectasis (HP:0100750) | 1.39089882 |
| 166 | Brushfield spots (HP:0001088) | 1.38586589 |
| 167 | Abnormality of the diencephalon (HP:0010662) | 1.38037709 |
| 168 | Anophthalmia (HP:0000528) | 1.37853410 |
| 169 | Shoulder girdle muscle weakness (HP:0003547) | 1.36656563 |
| 170 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.35465787 |
| 171 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.35465787 |
| 172 | Patchy hypopigmentation of hair (HP:0011365) | 1.34743656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.50246738 |
| 2 | NTRK3 | 3.33870132 |
| 3 | MAP3K9 | 2.73480426 |
| 4 | MARK1 | 2.62195889 |
| 5 | EPHB2 | 2.52253678 |
| 6 | NTRK1 | 2.33097520 |
| 7 | STK39 | 2.23362700 |
| 8 | BCKDK | 2.22791685 |
| 9 | MINK1 | 2.17137082 |
| 10 | PHKG2 | 2.16830116 |
| 11 | PHKG1 | 2.16830116 |
| 12 | NTRK2 | 2.11171357 |
| 13 | PRKD3 | 2.00918891 |
| 14 | TNIK | 1.98947975 |
| 15 | PAK6 | 1.96850109 |
| 16 | KSR2 | 1.95622660 |
| 17 | LMTK2 | 1.94308931 |
| 18 | MAP4K2 | 1.91674632 |
| 19 | WNK4 | 1.90611778 |
| 20 | MAP3K4 | 1.89112048 |
| 21 | OXSR1 | 1.79454342 |
| 22 | EPHA3 | 1.78690917 |
| 23 | CSNK1G1 | 1.77846347 |
| 24 | TESK1 | 1.74495386 |
| 25 | ARAF | 1.74219225 |
| 26 | CASK | 1.72416014 |
| 27 | KSR1 | 1.71377040 |
| 28 | MAP2K7 | 1.65503699 |
| 29 | UHMK1 | 1.62939797 |
| 30 | BCR | 1.56020902 |
| 31 | PAK3 | 1.50829723 |
| 32 | CDK5 | 1.44542522 |
| 33 | PNCK | 1.43002328 |
| 34 | WNK3 | 1.41143419 |
| 35 | TRIM28 | 1.39690573 |
| 36 | MAPK13 | 1.38921667 |
| 37 | LIMK1 | 1.37747952 |
| 38 | EPHB1 | 1.35096079 |
| 39 | CAMKK2 | 1.33321730 |
| 40 | EPHA2 | 1.31591144 |
| 41 | CDK19 | 1.30268861 |
| 42 | PLK2 | 1.29861736 |
| 43 | MAPK15 | 1.21905467 |
| 44 | MAP3K12 | 1.19217421 |
| 45 | TYRO3 | 1.15790155 |
| 46 | CAMK2B | 1.15640912 |
| 47 | MAP3K13 | 1.15412353 |
| 48 | MAP3K2 | 1.12437752 |
| 49 | WNK1 | 1.12011831 |
| 50 | NEK1 | 1.10762850 |
| 51 | CAMK2D | 1.10188705 |
| 52 | CAMK2A | 1.09165303 |
| 53 | MUSK | 1.07256123 |
| 54 | MET | 1.06804850 |
| 55 | CDK14 | 1.05390672 |
| 56 | SGK223 | 1.04999446 |
| 57 | SGK494 | 1.04999446 |
| 58 | NME1 | 1.04310695 |
| 59 | ROCK2 | 1.03854588 |
| 60 | CAMKK1 | 1.03363996 |
| 61 | PRPF4B | 1.02049238 |
| 62 | GRK5 | 0.99837246 |
| 63 | DAPK2 | 0.97184041 |
| 64 | DYRK1B | 0.93560199 |
| 65 | DDR2 | 0.92214203 |
| 66 | CDK18 | 0.92042921 |
| 67 | RIPK4 | 0.91248856 |
| 68 | NEK9 | 0.90970843 |
| 69 | CDK15 | 0.89925522 |
| 70 | PRKCG | 0.89801251 |
| 71 | CSNK1G2 | 0.89025257 |
| 72 | MAPKAPK5 | 0.87994458 |
| 73 | DYRK3 | 0.86433347 |
| 74 | OBSCN | 0.86049084 |
| 75 | MAP2K4 | 0.84868761 |
| 76 | RPS6KA4 | 0.84509856 |
| 77 | PRKCE | 0.83393136 |
| 78 | DYRK1A | 0.83334501 |
| 79 | CDK11A | 0.78545255 |
| 80 | CAMK2G | 0.77512297 |
| 81 | NEK6 | 0.76932503 |
| 82 | MST1R | 0.76420105 |
| 83 | FER | 0.74037825 |
| 84 | PKN1 | 0.71974110 |
| 85 | ERBB2 | 0.71634538 |
| 86 | FGR | 0.69682275 |
| 87 | STK38L | 0.69628352 |
| 88 | BMPR2 | 0.69490868 |
| 89 | CSNK1G3 | 0.67507738 |
| 90 | PTK2B | 0.65700778 |
| 91 | SRPK1 | 0.65188011 |
| 92 | RET | 0.62270481 |
| 93 | PINK1 | 0.60242655 |
| 94 | DYRK2 | 0.58828267 |
| 95 | PIK3CA | 0.58240487 |
| 96 | ERBB3 | 0.58075436 |
| 97 | CSNK1A1 | 0.57693359 |
| 98 | MOS | 0.57680109 |
| 99 | TIE1 | 0.56068138 |
| 100 | FES | 0.55718634 |
| 101 | PBK | 0.54276206 |
| 102 | ADRBK1 | 0.54227534 |
| 103 | RIPK1 | 0.52699725 |
| 104 | SCYL2 | 0.52450425 |
| 105 | BMPR1B | 0.51666953 |
| 106 | MAP2K1 | 0.51096749 |
| 107 | IRAK2 | 0.50085625 |
| 108 | GRK7 | 0.49705070 |
| 109 | CCNB1 | 0.48930279 |
| 110 | CAMK1 | 0.48777050 |
| 111 | RAF1 | 0.48767735 |
| 112 | MAP3K1 | 0.48376192 |
| 113 | CSNK1A1L | 0.48264428 |
| 114 | ROCK1 | 0.47950441 |
| 115 | CDK6 | 0.47479973 |
| 116 | DMPK | 0.47147528 |
| 117 | INSRR | 0.46342634 |
| 118 | SGK1 | 0.46101014 |
| 119 | AKT2 | 0.45407272 |
| 120 | CAMK1G | 0.44803187 |
| 121 | MARK2 | 0.44323542 |
| 122 | HIPK2 | 0.44133475 |
| 123 | FGFR2 | 0.43972230 |
| 124 | PRKCH | 0.43521162 |
| 125 | PIM2 | 0.42027949 |
| 126 | PRKACA | 0.41261412 |
| 127 | PRKCZ | 0.40563450 |
| 128 | LATS2 | 0.39286515 |
| 129 | PDGFRA | 0.38550372 |
| 130 | GRK1 | 0.38087309 |
| 131 | SRC | 0.34550885 |
| 132 | CDK3 | 0.33798290 |
| 133 | ERBB4 | 0.32672979 |
| 134 | ABL2 | 0.31521345 |
| 135 | PAK4 | 0.31299080 |
| 136 | PTK2 | 0.30923433 |
| 137 | PRKACG | 0.29841034 |
| 138 | PRKAA1 | 0.29731375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.97057200 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.67429275 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.55315104 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.35920495 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.33548741 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.30356042 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.18592417 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.17797575 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.14939913 |
| 10 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.05509522 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 2.03504366 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.99851873 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.92529321 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92316908 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.90994178 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.90091056 |
| 17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.86754861 |
| 18 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.86203296 |
| 19 | Long-term potentiation_Homo sapiens_hsa04720 | 1.85852725 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.83799917 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.81131725 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.77478834 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.76472941 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.73824640 |
| 25 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.73250689 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.72648086 |
| 27 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.69031002 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.68378825 |
| 29 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.65900879 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64434033 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.63113133 |
| 32 | Parkinsons disease_Homo sapiens_hsa05012 | 1.62889659 |
| 33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.61623955 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.58626854 |
| 35 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.58467186 |
| 36 | Long-term depression_Homo sapiens_hsa04730 | 1.53563719 |
| 37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.52928772 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 1.52799979 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.48400609 |
| 40 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.46660795 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.43682960 |
| 42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.36329489 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.35881415 |
| 44 | Gap junction_Homo sapiens_hsa04540 | 1.35007969 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 1.34361752 |
| 46 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.31796182 |
| 47 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.30380116 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.29987810 |
| 49 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.29039364 |
| 50 | Axon guidance_Homo sapiens_hsa04360 | 1.28253512 |
| 51 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.26596325 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.24714186 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.22187379 |
| 54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.22139465 |
| 55 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.20936533 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.20323027 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20178234 |
| 58 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.15344721 |
| 59 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15231346 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10215568 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09185453 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.08999521 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.08303308 |
| 64 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.07315814 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.07184848 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07169329 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.06514932 |
| 68 | Melanogenesis_Homo sapiens_hsa04916 | 1.05657381 |
| 69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.02010763 |
| 70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.01631830 |
| 71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.98010816 |
| 72 | Huntingtons disease_Homo sapiens_hsa05016 | 0.97943143 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.97260074 |
| 74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.95661441 |
| 75 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.95489472 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.94802982 |
| 77 | Phototransduction_Homo sapiens_hsa04744 | 0.94788069 |
| 78 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.93908196 |
| 79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.93896794 |
| 80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92212924 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92194335 |
| 82 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.90570318 |
| 83 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90394394 |
| 84 | Bile secretion_Homo sapiens_hsa04976 | 0.89477987 |
| 85 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89433925 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.87320655 |
| 87 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.86921652 |
| 88 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.85813685 |
| 89 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85715453 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.85290173 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83678870 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81962930 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81583231 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79652913 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78677024 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78412880 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78295860 |
| 98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.76740653 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75006529 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74565157 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73395954 |
| 102 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.72651899 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71304590 |
| 104 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.71137550 |
| 105 | Glioma_Homo sapiens_hsa05214 | 0.70621594 |
| 106 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70302219 |
| 107 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.68661830 |
| 108 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68156100 |
| 109 | Protein export_Homo sapiens_hsa03060 | 0.67596678 |
| 110 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67441350 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66559354 |
| 112 | Alcoholism_Homo sapiens_hsa05034 | 0.65702126 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.65675108 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65501448 |
| 115 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.65501242 |
| 116 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.65303894 |
| 117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64510639 |
| 118 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64051222 |
| 119 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.64038146 |
| 120 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.62970509 |
| 121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.61326659 |
| 122 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60611821 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.60409833 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60309078 |
| 125 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60005272 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58253355 |
| 127 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57674497 |
| 128 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57194299 |
| 129 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56602254 |
| 130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56519406 |
| 131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53710744 |
| 132 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53628406 |
| 133 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.52790018 |
| 134 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52736318 |
| 135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51939232 |
| 136 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.51882783 |
| 137 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51856188 |
| 138 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.51745523 |
| 139 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51250208 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | 0.50052766 |
| 141 | Tight junction_Homo sapiens_hsa04530 | 0.49276003 |
| 142 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48999289 |
| 143 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.46662848 |
| 144 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45986502 |
| 145 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45060255 |
| 146 | Endocytosis_Homo sapiens_hsa04144 | 0.44587242 |
| 147 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.43652206 |
| 148 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.40583923 |
| 149 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39773166 |
| 150 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39493434 |
| 151 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39078926 |

